Catalyst Wire Dossier Catalyst Wire Dossier

BCMA/GPRC5D CAR-T therapy

BCMA/GPRC5D CAR-T cells · Guangzhou Bio-gene Technology Co., Ltd
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for BCMA/GPRC5D CAR-T therapy, covering 2024-10-16 to 2025-09-29. Get the full timeline:

Most recent: Clinical Trial Update: BCMA/GPRC5D CAR-T Therapy for Multiple Myeloma [EARLY_Phase 1]

See pricing